Role of and the axis in regulating telomerase expression in chronic lymphocytic leukemia.
作者信息
Rampazzo Enrica, Bojnik Engin, Trentin Livio, Bonaldi Laura, Del Bianco Paola, Frezzato Federica, Visentin Andrea, Facco Monica, Semenzato Gianpietro, De Rossi Anita
机构信息
Department of Surgery, Oncology and Gastroenterology, Section of Oncology and Immunology, University of Padova.
Department of Clinical and Experimental Medicine, Hematology Section, University of Padova.
出版信息
Haematologica. 2017 Jul;102(7):e253-e256. doi: 10.3324/haematol.2016.157669. Epub 2017 Apr 6.
Abstract
摘要
相似文献
1
Role of and the axis in regulating telomerase expression in chronic lymphocytic leukemia.[具体内容]及[具体内容]轴在慢性淋巴细胞白血病中调节端粒酶表达的作用。 （你提供的原文有部分缺失内容，已按格式要求进行翻译，完整准确的翻译需补充完整原文信息）
Haematologica. 2017 Jul;102(7):e253-e256. doi: 10.3324/haematol.2016.157669. Epub 2017 Apr 6.
2
NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia.慢性淋巴细胞白血病中 NDRG2 mRNA 水平及 miR-28-5p 和 miR-650 的活性。
BMC Cancer. 2018 Oct 22;18(1):1009. doi: 10.1186/s12885-018-4915-3.
3
The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.在慢性淋巴细胞白血病细胞中，通过上调miR-132，B细胞受体触发时SIRT1/TP53轴被激活。
Oncotarget. 2015 Aug 7;6(22):19102-17. doi: 10.18632/oncotarget.3905.
4
Increased expression of E3 ubiquitin ligases targeting p53 in CLL patients with wild-type TP53 exhibits associations with clinical features of the disease.
Leuk Lymphoma. 2016;57(6):1471-3. doi: 10.3109/10428194.2015.1096355. Epub 2015 Nov 16.
5
The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients.肿瘤抑制轴p53/miR-34a调节B细胞慢性淋巴细胞白血病中的Axl表达：对p53缺陷型慢性淋巴细胞白血病患者治疗的意义。
Leukemia. 2014 Feb;28(2):451-5. doi: 10.1038/leu.2013.298. Epub 2013 Oct 18.
6
Inactivation of TP53 correlates with disease progression and low miR-34a expression in previously treated chronic lymphocytic leukemia patients.在先前治疗的慢性淋巴细胞白血病患者中，TP53 的失活与疾病进展和低 miR-34a 表达相关。
Blood. 2013 May 2;121(18):3650-7. doi: 10.1182/blood-2012-10-458695. Epub 2013 Mar 22.
7
Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.外周血单个核细胞中miR-20b-5p表达升高：慢性淋巴细胞白血病预后良好的一种新型独立分子生物标志物。
Leuk Res. 2018 Jul;70:1-7. doi: 10.1016/j.leukres.2018.04.014. Epub 2018 Apr 26.
8
miR-34a as part of the resistance network in chronic lymphocytic leukemia.微小RNA-34a作为慢性淋巴细胞白血病耐药网络的一部分。
Blood. 2009 Apr 16;113(16):3801-8. doi: 10.1182/blood-2008-08-172254. Epub 2008 Oct 21.
9
Telomere status in chronic lymphocytic leukemia with TP53 disruption.伴有TP53基因破坏的慢性淋巴细胞白血病中的端粒状态
Oncotarget. 2016 Aug 30;7(35):56976-56985. doi: 10.18632/oncotarget.10927.
10
Protein expression analysis of chronic lymphocytic leukemia defines the effect of genetic aberrations and uncovers a correlation of CDK4, P27 and P53 with hierarchical risk.慢性淋巴细胞白血病的蛋白表达分析定义了遗传异常的影响，并揭示了 CDK4、P27 和 P53 与分层风险的相关性。
Haematologica. 2010 Nov;95(11):1880-8. doi: 10.3324/haematol.2010.025734. Epub 2010 Aug 16.
引用本文的文献
1
Beyond Telomeres: Unveiling the Extratelomeric Functions of TERT in B-Cell Malignancies.超越端粒：揭示端粒酶逆转录酶在B细胞恶性肿瘤中的端粒外功能
Cancers (Basel). 2025 Mar 30;17(7):1165. doi: 10.3390/cancers17071165.
2
Dysregulated MicroRNAs in Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病中失调的微小RNA
Cureus. 2024 Sep 6;16(9):e68770. doi: 10.7759/cureus.68770. eCollection 2024 Sep.
3
Mechanism of Human Telomerase Reverse Transcriptase () Regulation and Clinical Impacts in Leukemia.人类端粒酶逆转录酶（）的调节机制及其在白血病中的临床影响。
Genes (Basel). 2021 Jul 30;12(8):1188. doi: 10.3390/genes12081188.
4
Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer.微小RNA在卵巢癌基因组稳定性和应激反应中的当前意义
Cancers (Basel). 2021 May 29;13(11):2690. doi: 10.3390/cancers13112690.
5
MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia.微小RNA：在正常B细胞发育和B细胞慢性淋巴细胞白血病中起关键作用的基因表达微小调节因子
Cancers (Basel). 2021 Feb 3;13(4):593. doi: 10.3390/cancers13040593.
6
Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active Targets.慢性淋巴细胞白血病中的肿瘤抑制因子：从失配伙伴到活性靶点
Cancers (Basel). 2020 Mar 9;12(3):629. doi: 10.3390/cancers12030629.
7
Role of Non-Coding RNAs in the Development of Targeted Therapy and Immunotherapy Approaches for Chronic Lymphocytic Leukemia.非编码RNA在慢性淋巴细胞白血病靶向治疗和免疫治疗方法发展中的作用
J Clin Med. 2020 Feb 21;9(2):593. doi: 10.3390/jcm9020593.
8
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.复杂核型亚型与IGHV 突变状态的联合可确定慢性淋巴细胞白血病中的新预后和预测分组。
Br J Cancer. 2019 Jul;121(2):150-156. doi: 10.1038/s41416-019-0502-x. Epub 2019 Jun 18.
9
The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.血浆端粒酶逆转录酶（TERT）RNA 在直肠癌患者中的预测和预后潜力。
Br J Cancer. 2018 Mar 20;118(6):878-886. doi: 10.1038/bjc.2017.492. Epub 2018 Feb 15.
本文引用的文献
1
Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.预测当代慢性淋巴细胞白血病的预后。
JAMA Oncol. 2015 Oct;1(7):965-74. doi: 10.1001/jamaoncol.2015.0779.
2
Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.端粒/端粒酶系统损伤在早期慢性淋巴细胞白血病中的相关性
Genes Chromosomes Cancer. 2014 Jul;53(7):612-21. doi: 10.1002/gcc.22171. Epub 2014 Apr 4.
3
The role of TP53 network in the pathogenesis of chronic lymphocytic leukemia.TP53网络在慢性淋巴细胞白血病发病机制中的作用。
Int J Clin Exp Pathol. 2013 Jun 15;6(7):1223-9. Print 2013.
4
Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia.端粒长度和人类端粒酶逆转录酶剪接变异体在慢性淋巴细胞白血病中的表达。
Exp Hematol. 2013 Jul;41(7):615-26. doi: 10.1016/j.exphem.2013.03.008. Epub 2013 Mar 30.
5
Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.13q14 大量缺失的慢性淋巴细胞白血病患者的分子特征。
PLoS One. 2012;7(11):e48485. doi: 10.1371/journal.pone.0048485. Epub 2012 Nov 13.
6
Regulation of the human catalytic subunit of telomerase (hTERT).端粒酶人催化亚基（hTERT）的调节。
Gene. 2012 May 1;498(2):135-46. doi: 10.1016/j.gene.2012.01.095. Epub 2012 Feb 13.
7
Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.端粒长度和端粒酶水平可区分具有不同生物学特征和临床结局的 B 细胞慢性淋巴细胞白血病亚群。
Haematologica. 2012 Jan;97(1):56-63. doi: 10.3324/haematol.2011.049874. Epub 2011 Sep 20.
8
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.miRNA/TP53 反馈回路与 B 细胞慢性淋巴细胞白血病发病机制和预后的关联。
JAMA. 2011 Jan 5;305(1):59-67. doi: 10.1001/jama.2010.1919.
9
Telomere/telomerase interplay in virus-driven and virus-independent lymphomagenesis: pathogenic and clinical implications.端粒/端粒酶相互作用在病毒驱动和非病毒驱动的淋巴瘤发生中的作用：发病机制和临床意义。
Med Res Rev. 2012 Mar;32(2):233-53. doi: 10.1002/med.20211. Epub 2010 Jun 14.
10
MicroRNAs.微小核糖核酸
Cancer J. 2008 Jan-Feb;14(1):1-6. doi: 10.1097/PPO.0b013e318164145e.
Zotero 插件